Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|February 23, 2013
Characterization of proprotein convertase subtilisin/kexin type 9 (PCSK9) trafficking reveals a novel lysosomal targeting mechanism via amyloid precursor-like protein 2 (APLP2)Rachel M DeVay, David L Shelton, Hong Liang
Plos One|April 24, 2015
Common Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Epitopes Mediate Multiple Routes for Internalization and FunctionRachel M DeVay, Lynn Yamamoto, David L Shelton, et al.
The Journal of Cell Biology|September 16, 2009
Coassembly of Mgm1 isoforms requires cardiolipin and mediates mitochondrial inner membrane fusionRachel M DeVay, Lenin Dominguez-Ramirez, Laura L Lackner, et al.
Cardiovascular Research|March 17, 2016
Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanismsHagai Tavori, Ilaria Giunzioni, Irene M Predazzi, et al.
The Journal of Cell Biology|October 12, 2011
A mitochondrial-focused genetic interaction map reveals a scaffold-like complex required for inner membrane organization in mitochondriaSuzanne Hoppins, Sean R Collins, Ann Cassidy-Stone, et al.
The Journal of Pathology|September 4, 2015
Local effects of human PCSK9 on the atherosclerotic lesionIlaria Giunzioni, Hagai Tavori, Roman Covarrubias, et al.
Bioconjugate Chemistry|February 3, 2017
Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug ConjugatesRachel M DeVay, Kathy Delaria, Guoyun Zhu, et al.
The Journal of Biological Chemistry|February 2, 2012
Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9Javier Chaparro-Riggers, Hong Liang, Rachel M DeVay, et al.
Pageof 1